Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
55 hedge funds and large institutions have $34.1M invested in Applied Genetic Technologies Corporation in 2019 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 5 closing their positions.
180% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 5
32% more capital invested
Capital invested by funds: $25.9M → $34.1M (+$8.24M)
20% more funds holding
Funds holding: 46 → 55 (+9)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.53M |
| 2 |
6CM
683 Capital Management
New York
|
+$1.29M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$501K |
| 4 |
Renaissance Technologies
New York
|
+$337K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$305K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$356K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$279K |
| 3 |
Two Sigma Investments
New York
|
-$132K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$47.5K |
| 5 |
BlackRock
New York
|
-$47K |
AGTC Hedge Fund Activity: Q3 2019 in Review
55 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q3 2019, worth a combined $34.1M — up 32% from $25.9M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new AGTC positions and 5 closed out — a net gain of 9 holders — while 10 added to existing stakes and 13 trimmed.
The largest buyer was Acadian Asset Management, opening a new position worth an estimated $2.53M. The largest seller was Assenagon Asset Management, exiting entirely with an estimated $356K sold.
- 55 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q3 2019, up from 46 in Q2 2019.
- Funds reported $34.1M of Applied Genetic Technologies Corporation stock for Q3 2019, up 32% quarter-over-quarter.
- 14 funds opened new Applied Genetic Technologies Corporation positions in Q3 2019 and 5 closed out, a net change of +9 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q3 2019 was Acadian Asset Management, an estimated $2.53M added.
- The largest Applied Genetic Technologies Corporation seller in Q3 2019 was Assenagon Asset Management, an estimated $356K sold.
Based on aggregated 13F filings for Q3 2019.